Hakan Cebeci

Dr. Hakan Cebeci

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in European Journal of Radiology
Verified
Journal Article
Closed access
HCHakan Cebeci
Hakan Cebeci
OAO Aydin
O Aydin
EOEsin Ozturk-Isik
Esin Ozturk-Isik
CGC Gumus
C Gumus
FIF Inecikli
F Inecikli
BHB Hakyemez
B Hakyemez

18 July 2018 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
MBMücahid Barstuğan
Mücahid Barstuğan
RCRahime Ceylan
Rahime Ceylan
SASemih Asoglu
Semih Asoglu
HCHakan Cebeci
Hakan Cebeci
MKMustafa Koplay
Mustafa Koplay

20 January 2022 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
OUOnur Ural
Onur Ural
HKHatice Esranur Kıratlı
Hatice Esranur Kıratlı
SSSua Sumer
Sua Sumer
NDNazlım Aktuğ Demir
Nazlım Aktuğ Demir
SKSema Yılmaz Kırık
Sema Yılmaz Kırık
LDLütfi Saltuk Demir
Lütfi Saltuk Demir
Coronavirus disease 2019 (COVID-19) is a global health problem caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 infection may present with clinical pictures ranging from asymptomatic or mild forms to respiratory failure requiring intensive care follow-up and mechanical ventilation. The course of this disease with different clinical presentations raises many immunological questions. This study aimed to evaluate the serum levels of Annexin-1 (ANXA-1), Annexin-2 (ANXA-2) and bone morphogenetic protein-7 (BMP-7) in patients diagnosed with COVID-19 and to investigate whether these markers are associated with lung involvement. The study was conducted in 173 patients who were followed and treated with the diagnosis of COVID-19 and 51 healthy control group. Patients were primarily divided into two groups based on the presence of typical lung involvement (ground glass opacities, consolidation, and both) in the thoracic computed tomography (CT) scans for COVID-19. Those who found to have involvement in thoracic CT scans were divided into three groups as mild (< 33%), moderate (34-66%), and severe (> 67%) according to the extent of their lesions. Of the 173 patients included in the study, 130 had typical thoracic CT involvement for COVID-19, while 43 did not. ANXA-1, ANXA-2 and BMP-7 values were found to be higher in the patients than the control group (p=0.001, p=0.001, p=0.001). ANXA-2 levels were higher in patients with thoracic CT involvement than those without thoracic CT involvement (p=0.023). In addition, when the patients were evaluated according to their thorax CT involvement levels, it was found that as the lung involvement levels increased, ANXA-2 increased, ANXA-1 decreased, and BMP-7 levels did not change. While the increase in ANXA-2 was statistically significant, the decrease in ANXA-1 was not found statistically significant. When the relationship between the laboratory parameters and the thorax CT involvement level was evaluated; it was found that, the lymphocyte and thrombocyte counts decreased as the thorax CT involvement increased, and lactate dehydrogenase (LDH), ferritin, procalcitonin (PCT), C-reactive protein (CRP), D-dimer and troponin levels were increased. While no significant correlation was found between ANXA-1 and BMP-7 and laboratory parameters, a positive correlation was found between ANXA-2 and leukocyte count, LDH, troponin, PCT, ferritin, D-dimer, and CRP. The data obtained in our study suggest that the ANXA-2 level at the time of admission was related with the lung involvement and the level of involvement of the disease. As a result, molecular studies are needed today to understand the pathogenesis of COVID-19 and to investigate new treatment targets. Evaluation of ANXA-2 level may be important in predicting the level of lung involvement due to COVID-19.


28 September 2020 in Journal of Ultrasonography
Verified
Journal Article
Open access
HCHakan Cebeci
Hakan Cebeci
MÖMehmet Öztürk
Mehmet Öztürk
MDMehmet Sedat Durmaz
Mehmet Sedat Durmaz
AKAbidin Kılınçer
Abidin Kılınçer
ÖEÖmer Erdur
Ömer Erdur
BÇBahar Çolpan
Bahar Çolpan
Aim of the study: This study aimed to examine the role of superb microvascular imaging and shear wave elastography for the pre-surgical evaluation of common parotid tumors. Material and methods: This single-center prospective study included 37 patients with parotid gland lesions. After institutional review board approval, grayscale, shear wave elastography and superb microvascular imaging ultrasound examinations were performed prior to biopsy or operation. The diagnosis of the lesions was based on cytological/pathological evaluation after the ultrasound examinations. Pleomorphic adenomas and Warthin tumors were compared using the Mann–Whitney U test. A receiver operating characteristic curve analysis was performed to obtain a cut-off value. A multivariate regression analysis was carried out. Results: The mean age of the patients (11 female, 26 male) was 48.2 ± 18. The shear wave elastography parameters of the lesions were not significantly different between pleomorphic adenomas and Warthin tumors, while the vascular index obtained by using superb microvascular imaging was significantly different (p = 0.012). The mean vascular index was 2.9 ± 3.1 in pleomorphic adenomas, and 9.5 ± 9.5 in Warthin tumors. A cut-off value of 4.05 for the vascular index discriminated pleomorphic adenoma and Warthin tumors with 68% sensitivity and 72% specificity (the area under the curve was 0.768). Conclusion: Superb microvascular imaging is a novel ultrasound imaging technique which is useful for the discrimination of pleomorphic adenomas and Warthin tumors.

1 August 2020 in Clinical Imaging
Verified
Journal Article
Closed access
HCHakan Cebeci
Hakan Cebeci
MDMehmet Sedat Durmaz
Mehmet Sedat Durmaz
SASerdar Arslan
Serdar Arslan
AAAbdullah Arslan
Abdullah Arslan
ATAli Fuat Tekin
Ali Fuat Tekin
RKRamazan Koylu
Ramazan Koylu